Trials / Terminated
TerminatedNCT01584752
Gore-BioA Fistula Plug to Treat Transsphincteric Fistulas
Clinical Multicenter Study of the Efficacy of Gore-BioA Fistula Plug in High Transsphincteric Perianal Fistulas
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- Central Finland Hospital District · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective clinical study on the efficacy of Gore-BioA fistula plug in high transsphincteric fistulas. Follow-up time is six months
Detailed description
Inclusion criteria for the study is a patient with ultrasound or MRI proven high transsphincteric perianal fistula. Patients with Crohns disease, immunosuppressive medication, anovaginal fistula, radiation therapy or chemotherapy are excluded. A Seton is placed in the fistula track for two months before the application of the plug. Patients are followed up for six months. Symptoms of fecal incontinence before and after intervention are monitored with the Cleveland clinic incontinence score.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Gore-BioA Fistula Plug | Gore-BioA Fistula Plug |
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2014-12-01
- Completion
- 2015-11-01
- First posted
- 2012-04-25
- Last updated
- 2019-07-26
Locations
7 sites across 1 country: Finland
Source: ClinicalTrials.gov record NCT01584752. Inclusion in this directory is not an endorsement.